Cubist Systematic Strategies’s Nautilus Biotechnolgy NAUT Stock Holding History

Cubist Systematic Strategies’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1	Sell	1 -62,346	-100%	-$45.8K	﹤0.01%	2948
2025 Q2	$45.2K	Buy	+62,347	New	+$46.8K	﹤0.01%	2788
2025 Q1	–	Sell	-20,256	Closed	-$34K	–	3285
2024 Q4	$34K	Buy	+20,256	New	+$48.5K	﹤0.01%	2817
2022 Q4	–	Sell	-15,577	Closed	-$33K	–	4473
2022 Q3	$33K	Buy	15,577 +3,077	+25%	+$7.74K	﹤0.01%	4181
2022 Q2	$34K	Sell	12,500 -14,690	-54%	-$54.7K	﹤0.01%	4156
2022 Q1	$118K	Sell	27,190 -42,744	-61%	-$175K	﹤0.01%	3198
2021 Q4	$362K	Sell	69,934 -4,547	-6%	-$24.3K	﹤0.01%	2665
2021 Q3	$457K	Buy	74,481 +71,731	+2,608%	+$572K	0.01%	2097
2021 Q2	$28K	Buy	+2,750	New	+$29.8K	﹤0.01%	2834

Other funds holding NAUT

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cubist Systematic Strategies's NAUT Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Nautilus Biotechnolgy (NAUT) stake by 100% in Q3 2025, selling an estimated $45.8K and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Cubist Systematic Strategies first reported a position in NAUT in Q2 2021 and has held it in 9 quarters since. The position peaked at $457K in Q3 2021. 68 funds tracked by Wall St. Rank hold NAUT as of Q3 2025.

Cubist Systematic Strategies held 1 share of Nautilus Biotechnolgy worth $1 as of Q3 2025.
Cubist Systematic Strategies sold 62,346 Nautilus Biotechnolgy shares in Q3 2025, an estimated $45.8K.
Nautilus Biotechnolgy made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2948 holding.
Cubist Systematic Strategies first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 9 quarters since.
Cubist Systematic Strategies's Nautilus Biotechnolgy position peaked at $457K in Q3 2021.
68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.